OrsoBio is a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to address severe metabolic disorders such as obesity, diabetes, and NASH. With a skilled team of physicians and scientists, the company is dedicated to tackling the root causes of organ dysfunction in these conditions. Founded by Dr. Mani Subramanian, OrsoBio leverages decades of experience in clinical research and drug development to create innovative treatments aimed at improving metabolic health.